542 filings
Page 5 of 28
SC 13G/A
LJPC
La Jolla Pharmaceutical Co.
7 Feb 20
Beneficial ownership report (amended)
10:06am
SC 13G/A
NTRA
Natera Inc
7 Feb 20
Natera, Inc.
12:00am
SC 13G/A
Jennison Associates LLC
7 Feb 20
resTORbio, Inc.
12:00am
SC 13G/A
Jennison Associates LLC
4 Feb 20
Beneficial ownership report (amended)
3:57pm
SC 13G/A
Jennison Associates LLC
4 Feb 20
Beneficial ownership report (amended)
3:49pm
SC 13G/A
FOLD
Amicus Therapeutics Inc
4 Feb 20
Beneficial ownership report (amended)
3:40pm
SC 13G/A
Jennison Associates LLC
4 Feb 20
Assembly Biosciences, Inc.
3:15pm
SC 13E3/A
Jennison Associates LLC
4 Feb 20
Going private transaction (amended)
2:59pm
SC 13G
Jennison Associates LLC
4 Feb 20
Beneficial ownership report
2:40pm
SC 13G/A
Jennison Associates LLC
4 Feb 20
Beneficial ownership report (amended)
2:20pm
SC 13G/A
Jennison Associates LLC
4 Feb 20
Biomarin Pharmaceutical Inc
2:12pm
SC 13G/A
Jennison Associates LLC
3 Feb 20
Beneficial ownership report (amended)
4:13pm
SC 13G/A
ALB
Albemarle Corp.
3 Feb 20
Beneficial ownership report (amended)
3:50pm
SC 13G/A
Jennison Associates LLC
3 Feb 20
Aileron Therapeutics Inc
3:24pm
SC 13G/A
SYRE
Spyre Therapeutics Inc.
3 Feb 20
Beneficial ownership report (amended)
2:43pm
SC 13G/A
AGRO
Adecoagro S.A.
3 Feb 20
Adecoagro S.A.
1:59pm
SC 13G/A
Jennison Associates LLC
8 Nov 19
Aileron Therapeutics Inc
4:38pm
13F-HR
Jennison Associates LLC
8 Nov 19
Quarterly holdings report by institutional manager
2:22pm
13F-HR/A
Jennison Associates LLC
13 Aug 19
Quarterly holdings report by institutional manager (amended)
1:01pm
13F-HR/A
Jennison Associates LLC
9 Aug 19
Quarterly holdings report by institutional manager (amended)
2:37pm